Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NR5A1 | Q13285 | 7/20 | 0.36 |
| ▸ | NR5A2 | O00482 | 6/20 | 0.36 |
| ▸ | CNR1 | P21554 | 3/20 | 0.36 |
| ▸ | CNR2 | P34972 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27817357 | 0.78 | MEN1 (0.42) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL18131885 | 0.77 | P2RX7 (0.39) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL7159754 | 0.75 | MEN1 (0.41) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL27825548 | 0.71 | CYP2C19 (0.40) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL28040132 | 0.70 | P2RX7 (0.40) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL27629796 | 0.69 | MEN1 (0.41) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL5418324 | 0.69 | P2RX7 (0.45) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL28003009 | 0.69 | MEN1 (0.42) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL22496025 | 0.69 | MEN1 (0.41) | CYP1A2CYP2C19P2RX7MEN1ALDH1A1 | |
| SCHEMBL1768748 | 0.68 | CYP1A2 (0.40) | CYP1A2CYP2C19MEN1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005065136-A2 | OIL IN SILICONE EMULSIONS AND COMPOSITIONS CONTAINING SAME | AVON PRODUCTS, INC. (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005065154-A2 | NOVEL ESTERS OF ARYL BENZIMIDAZOLE SULFONIC ACIDS AND SUNSCREEN COMPOSITIONS CONTAINING SAME | AVON PRODUCTS, INC. (US) | 2005-07-21 | — | — | WO | claimed |
| EP-3996670-A1 | POLYURETHANE GELS | Nanometics LLC (D.B.A. Phd Biosciences) (US) | 2022-05-18 | — | — | EP | disclosed |
| WO-2021007489-A1 | POLYURETHANE GELS | NANOMETICS LLC (D.B.A. PHD BIOSCIENCES) (US) | 2021-01-14 | — | — | WO | disclosed |
| EP-1928400-A2 | SKIN CARE COMPOSITION COMPRISING INTERFERENCE PIGMENTS | The Procter and Gamble Company (US) | 2008-06-11 | — | — | EP | disclosed |
| EP-1901817-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | The Procter and Gamble Company (US) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007031970-A2 | SKIN CARE COMPOSITION COMPRISING INTERFERENCE PIGMENTS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-22 | — | — | WO | disclosed |
| WO-2007007255-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-18 | — | — | WO | disclosed |
| WO-2005065136-A2 | OIL IN SILICONE EMULSIONS AND COMPOSITIONS CONTAINING SAME | AVON PRODUCTS, INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005065154-A2 | NOVEL ESTERS OF ARYL BENZIMIDAZOLE SULFONIC ACIDS AND SUNSCREEN COMPOSITIONS CONTAINING SAME | AVON PRODUCTS, INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| WO-1999049878-A1 | SKIN LIGHTENING COMPOSITION CONTAINING MAGNESIUM ASCORBYL PHOSPHATE AND UNINONTAN-U34TM (EXTRACT FORMULATION OF CUCUMBER EXTRACT AND LEMON EXTRACT) | MARY KAY INC. (US) | 1999-10-07 | — | — | WO | disclosed |